Researchers at Le Bonheur and the University of Tennessee Health Science Center have developed a topical cream that has positive results in the treatment facial lesions associated in Tuberous Sclerosis Complex (TSC). The initial study follows the treatment of two patients and was published online in the Journal of Child Neurology.